Perrigo (PRGO) Not Generic When It Comes to Growth Potential - Cramer
Tweet
Share
E-mail
Get Alerts PRGO Hot Sheet
Price: $14.25 +4.01%
Rating Summary:
12 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
12 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Perrigo (Nasdaq: PRGO) CEO Joe Papa made comments on Jim Cramer's Mad Money Tuesday night.
Papa reiterated Perrigo's fundamentals: delivering generics that offer the same safety and effectiveness of the national brands, cost 35 percent less to the customer, and offer better margins for retailers.
Recalls at Johnson & Johnson (NYSE: JNJ) afforded Perrigo the opportunity to pick up more shelf space, Papa noted.
Economic pressure in Europe is also affording Perrigo broader opportunities. In China, the company has already extended it's infant formula offerings.
Papa said of all drugs available via prescription only, about $10 billion is expected to go over-the-counter in the next five years. He's believes Perrigo is already a "fast follower" in that market.
Cramer reiterates his Buy recommendation on the stock.
Shares of Perrigo are up just 0.2 percent in pre-market action Wednesday.
Papa reiterated Perrigo's fundamentals: delivering generics that offer the same safety and effectiveness of the national brands, cost 35 percent less to the customer, and offer better margins for retailers.
Recalls at Johnson & Johnson (NYSE: JNJ) afforded Perrigo the opportunity to pick up more shelf space, Papa noted.
Economic pressure in Europe is also affording Perrigo broader opportunities. In China, the company has already extended it's infant formula offerings.
Papa said of all drugs available via prescription only, about $10 billion is expected to go over-the-counter in the next five years. He's believes Perrigo is already a "fast follower" in that market.
Cramer reiterates his Buy recommendation on the stock.
Shares of Perrigo are up just 0.2 percent in pre-market action Wednesday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
- Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'
- Deere (DE) PT Lowered to $728 at UBS as Agricultural Machinery Cycle Gets Closer
Create E-mail Alert Related Categories
Analyst Comments, Insiders' BlogRelated Entities
Jim CramerSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
